They were $1.27 on announcing the proposal; and instantly down afterwards most likely because the market realised that they would be tied to DDH (and since then the DDH core business has been in trouble).
I'll skip the lesson on "accountancy" thanks as that's the practice of being a professional accountant; and that'll largely be irrelevant on results day.
The takeover occurs after it's approved.
Based on your contributions I did cash out some of my PRN shares around November last year: you'll be pleased to know they went into a 6 bagger.
My best real life result was 53,500 times at its peak - interestingly, that tranche of shares eventually became worthless but I'm not concerned because it's all part of a portfolio.
You'll note I'm not pushing this on anyone - my sentiment is "hold held"; my contributions here just serve to correct your nonsense.
If you're going to use big words, please select the correct ones
- Forums
- ASX - By Stock
- PRN
- Ann: Barminco and MMG agree Khoemacau Copper extention
PRN
perenti limited
Add to My Watchlist
1.92%
!
$1.60

Ann: Barminco and MMG agree Khoemacau Copper extention, page-10
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.60 |
Change
0.030(1.92%) |
Mkt cap ! $1.480B |
Open | High | Low | Value | Volume |
$1.56 | $1.62 | $1.56 | $4.300M | 2.698M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8313 | $1.59 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.60 | 15272 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8313 | 1.590 |
1 | 8313 | 1.585 |
1 | 2895 | 1.575 |
1 | 40000 | 1.560 |
1 | 12862 | 1.555 |
Price($) | Vol. | No. |
---|---|---|
1.600 | 15272 | 1 |
1.605 | 6111 | 1 |
1.610 | 2722 | 2 |
1.615 | 12470 | 1 |
1.620 | 90809 | 4 |
Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
Featured News
PRN (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online